One of the maddening aspects of the GMO discourse is the conflation of industry concerns with science. The biggest example, of course, is the way Monsanto has become a proxy for anti-GMO sentiment. True, this dynamic is not unique to biotechnology. Debates on pharmaceuticals, energy, and agriculture revolve around multinational companies that are stand-ins for … Continue reading Talking Points